Target intelligence / Profile preview

TAR RNA-binding protein 2 (TRBP) (TRBP)

Target
TRBP
Molecular classification
RNA-binding protein, Double-stranded RNA-binding protein, RISC-loading complex subunit, Other
01

Overview

TAR RNA-binding protein 2 (TRBP) is a double-stranded RNA-binding protein that serves as a critical regulator of the RNA interference (RNAi) pathway and the cellular response to viral infection. It is a key component of the RISC-loading complex, where it partners with Dicer and Argonaute 2 to facilitate the processing of precursor microRNAs into mature miRNAs. Originally identified for its ability to bind the HIV-1 trans-activation response (TAR) RNA element, TRBP enhances viral gene expression and replication while simultaneously inhibiting the interferon-induced protein kinase R (PKR), a sensor that normally restricts translation during stress or infection. In various human pathologies, particularly cancer, TRBP is frequently overexpressed or mutated, leading to deregulated miRNA biogenesis and the suppression of innate immune defenses. As a result, TRBP is an attractive therapeutic target for antiviral and anticancer drug development, with research focusing on small molecules like enoxacin that can modulate its activity in miRNA processing. Experimental approaches using siRNAs to knock down TRBP have also demonstrated efficacy in inhibiting HIV-1 production. Overall, TRBP serves as a multifunctional hub connecting RNA processing, innate immunity, and viral pathogenesis.

Other names
TARBP2TRBP1TRBP2RISC-loading complex RNA-binding subunitTrans-activation response RNA-binding protein 2
02

Mechanism of action

Enoxacin acts as a small molecule enhancer of microRNA biogenesis by binding to the TRBP-Dicer complex to facilitate miRNA processing. Experimental siRNAs target TRBP mRNA for degradation to inhibit its role in viral replication and PKR suppression.

03

Biological functions

RNA interferenceMicroRNA biogenesisImmune responseCell proliferationSpermatogenesisOther
04

Disease associations

CancerInfectionNeurodegenerative diseaseCardiovascular diseaseOther
05

Safety considerations

Disruption of global RNA interferenceImpairment of spermatogenesisDevelopmental growth defectsSystemic toxicity from PKR overactivation
06

Interacting drugs

Enoxacin

1 more in the full profile.

07

Biomarkers

TRBP expression levelsTARBP2 mutationsMicrosatellite instabilitymiRNA expression profiles

Beyond the preview

Go deeper on TAR RNA-binding protein 2 (TRBP) (TRBP).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on TAR RNA-binding protein 2 (TRBP) (TRBP).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call